Skip to main content
Premium Trial:

Request an Annual Quote

NIH Awards TriLink $130K to Develop RNA Sample Prep Method for NGS

NEW YORK (GenomeWeb News) – TriLink BioTechnologies today announced a $130,000 award from the National Institutes of Health to develop a sample preparation method for next-generation sequencing.

The San Diego-based firm will use its expertise in nucleic acid chemistry as part of the Phase I Small Business Innovation Research grant to develop an approach to RNA sample prep, it said. The grant last through July.

TriLink will investigate methods of reducing the formation of adapters dimers during RNA sample prep, which would eliminate the need for gel purification prior to sequencing.

"Improving the process of RNA sample preparation for next generation sequencing will increase the accessibility of this valuable tool," Richard Hogrefe, CEO of TriLink, said in a statement.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.